Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jul 6;3(90):90ps27.
doi: 10.1126/scitranslmed.3001880.

Development of newborn and infant vaccines

Guzman Sanchez-Schmitz  1 , Ofer Levy
Affiliations

Development of newborn and infant vaccines

Guzman Sanchez-Schmitz et al. Sci Transl Med. .

Abstract

Vaccines for early-life immunization are a crucial biomedical intervention to reduce global morbidity and mortality, yet their developmental path has been largely ad hoc, empiric, and inconsistent. Immune responses of human newborns and infants are distinct and cannot be predicted from those of human adults or animal models. Therefore, understanding and modeling age-specific human immune responses will be vital to the rational design and development of safe and effective vaccines for newborns and infants.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Distinct humoral and cellular components of the neonatal immune system
Neonatal blood plasma contains a different proportion of key immunomodulatory components than older individuals, including the presence of maternal antibodies, high concentrations of immunomodulatory adenosine, and reduced concentrations of complement, which are important to adaptive immune responses. Differences in neonatal leukocytes include impaired migration and reduced Th1-polarizing responses of neonatal APCs to most TLR agonists. T cell impairments include diminished CD40 ligand expression and reduced IFN-γ production. Neonatal B cells are predominantly transitional and demonstrate impairments in antibody maturation and affinity. CREDIT: C. BICKEL/SCIENCE TRANSLATIONAL MEDICINE
Fig. 2
Fig. 2
See this image and copyright information in PMC

References

    1. Lawn JE, Cousens S, Zupan J. Lancet Neonatal Survival Steering Team, 4 million neonatal deaths: When? Where? Why? Lancet. 2005;365:891–900. Medline. - PubMed
    1. Bryce J, Daelmans B, Dwivedi A, Fauveau V, Lawn JE, Mason E, Newby H, Shankar A, Starrs A, Wardlaw T. Countdown Coverage Writing Group Countdown to 2015 Core Group, Countdown to 2015 for maternal, newborn, and child survival: The 2008 report on tracking coverage of interventions. Lancet. 2008;371:1247–1258. Medline. - PubMed
    1. WHO. Neonatal and perinatal mortality: Country, regional and global estimates. Geneva: 2006.
    1. Burton A, Monasch R, Lautenbach B, Gacic-Dobo M, Neill M, Karimov R, Wolfson L, Jones G, Birmingham M. WHO and UNICEF estimates of national infant immunization coverage: Methods and processes. Bull. World Health Organ. 2009;87:535–541. Medline. - PMC - PubMed
    1. Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: A review of evidence from community-based studies. Pediatr. Infect. Dis. J. 2009;28(Suppl):S3–S9. Medline. - PubMed

Publication types